| Year |
Title |
Altmetric |
| 2021
|
Analysis of glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein.
2021
|
|
| 2021
|
Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects.
Journal of Virology.
95.
2021
|
|
| 2021
|
Dual pathways of human immunodeficiency virus type 1 envelope glycoprotein trafficking modulate the selective exclusion of uncleaved oligomers from virions.
Journal of Virology.
95.
2021
|
|
| 2020
|
Author Correction: Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection (Nature Communications, (2020), 11, 1, (1767), 10.1038/s41467-020-15632-y).
Nature Communications.
11.
2020
|
|
| 2020
|
Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection.
Nature Communications.
11.
2020
|
|
| 2020
|
Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor.
Journal of Virology.
94.
2020
|
|
| 2020
|
Long-Acting bms-378806 analogues stabilize the state-1 conformation of the human immunodeficiency virus type 1 envelope glycoproteins.
Journal of Virology.
94.
2020
|
|
| 2020
|
Accumulated mutations by 6 months of infection collectively render transmitted/founder HIV-1 significantly less fit.
Journal of Infection.
80:210-218.
2020
|
|
| 2019
|
Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway.
Frontiers in Immunology.
10.
2019
|
|
| 2019
|
Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction.
PLoS ONE.
14.
2019
|
|
| 2019
|
Primary HIV-1 strains use nef to downmodulate HLA-E surface expression.
Journal of Virology.
93.
2019
|
|
| 2019
|
Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model.
Science Translational Medicine.
11.
2019
|
|
| 2019
|
Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).
Molecular and Cellular Endocrinology.
492.
2019
|
|
| 2018
|
Incomplete downregulation of CD4 expression affects HIV-1 Env conformation and antibody-dependent cellular cytotoxicity responses..
Journal of Virology.
92.
2018
|
|
| 2018
|
Structural stability of purified human CFTR is systematically improved by mutations in nucleotide binding domain 1
2018
|
|
| 2017
|
Potent in vivo NK cellmediated elimination of HIV-1-infected cells mobilized by a gp120-bispecific and hexavalent broadly neutralizing fusion protein.
Journal of Virology.
91.
2017
|
|
| 2017
|
Substitution of Yor1p NBD1 residues improves the thermal stability of human cystic fibrosis transmembrane conductance regulator
2017
|
|
| 2017
|
Glycosylation benchmark profile for HIV-1 envelope glycoprotein production based on eleven Env trimers.
Journal of Virology.
91.
2017
|
|
| 2017
|
Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies.
Science Translational Medicine.
9.
2017
|
|
| 2017
|
Dendritic cells from the human female reproductive tract rapidly capture and respond to HIV.
Mucosal Immunology.
10:531-544.
2017
|
|
| 2017
|
Evaluation of the contribution of the transmembrane region to the ectodomain conformation of the human immunodeficiency virus (HIV-1) envelope glycoprotein.
Virology Journal.
14.
2017
|
|
| 2017
|
Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs.
PLoS ONE.
12.
2017
|
|
| 2017
|
Specific stabilization of CFTR by phosphatidylserine
2017
|
|
| 2017
|
The transcriptome of HIV-1 infected intestinal CD4+ T cells exposed to enteric bacteria.
PLoS Pathogens.
13.
2017
|
|
| 2017
|
The cystic fibrosis transmembrane conductance regulator potentiator ivacaftor augments mucociliary clearance abrogating cystic fibrosis transmembrane conductance regulator inhibition by cigarette smoke.
American Journal of Respiratory Cell and Molecular Biology.
56:99-108.
2017
|
|
| 2016
|
Diversity of antiviral IgG effector activities observed in HIV-infected and vaccinated subjects.
Journal of Immunology.
197:4603-4612.
2016
|
|
| 2016
|
Expression and purification of the alpha subunit of the epithelial sodium channel, ENaC.
Protein Expression and Purification.
117:67-75.
2016
|
|
| 2016
|
Fisetin, a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma.
Oncotarget.
7:1227-1241.
2016
|
|
| 2016
|
High-throughput humanized mouse models for evaluation of HIV-1 therapeutics and pathogenesis.
Methods in Molecular Biology.
1354:221-235.
2016
|
|
| 2016
|
Inhibition of NADPH oxidase 1 activity and blocking the binding of cytosolic and membrane-bound proteins by honokiol inhibit migratory potential of melanoma cells.
Oncotarget.
7:7899-7912.
2016
|
|
| 2015
|
Optimized Replicating Renilla Luciferase Reporter HIV-1 Utilizing Novel Internal Ribosome Entry Site Elements for Native Nef Expression and Function.
AIDS Research and Human Retroviruses.
31:1278-1296.
2015
|
|
| 2015
|
A Stable Human-Cell System Overexpressing Cystic Fibrosis Transmembrane Conductance Regulator Recombinant Protein at the Cell Surface.
Molecular Biotechnology.
57:391-405.
2015
|
|
| 2015
|
Erratum to: A Stable Human-Cell System Overexpressing Cystic Fibrosis Transmembrane Conductance Regulator Recombinant Protein at the Cell Surface [Mol Biotechnol, DOI 10.1007/s12033-014-9830-5].
Molecular Biotechnology.
57:406.
2015
|
|
| 2015
|
Comparative analysis of the glycosylation profiles of membrane-anchored HIV-1 envelope glycoprotein trimers and soluble gp140.
Journal of Virology.
89:8245-8257.
2015
|
|
| 2015
|
In vivo activation of human NK cells by treatment with an interleukin-15 superagonist potently inhibits acute in vivo HIV-1 infection in humanized mice.
Journal of Virology.
89:6264-6274.
2015
|
|
| 2015
|
The vaginal acquisition and dissemination of HIV-1 infection in a novel transgenic mouse model is facilitated by coinfection with herpes simplex virus 2 and is inhibited by microbicide treatment.
Journal of Virology.
89:9559-9570.
2015
|
|
| 2015
|
Therapeutic intervention of proanthocyanidins on the migration capacity of melanoma cells is mediated through PGE2 receptors and β-catenin signaling molecules.
American Journal of Cancer Research.
5:3325-3338.
2015
|
|
| 2014
|
Macrophage infection via selective capture of HIV-1-infected CD4+ T cells.
Cell Host and Microbe.
16:711-721.
2014
|
|
| 2014
|
Combinatorial therapy with tamoxifen and trifluoperazine effectively inhibits malignant peripheral nerve sheath tumor growth by targeting complementary signaling cascades.
Journal of Neuropathology and Experimental Neurology.
73:1078-1090.
2014
|
|
| 2014
|
Global panel of HIV-1 env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies.
Journal of Virology.
88:2489-2507.
2014
|
|
| 2014
|
High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse.
Journal of Virology.
88:2025-2034.
2014
|
|
| 2014
|
Erratum: Resveratrol Enhances Airway Surface Liquid Depth in Sinonasal Epithelium by Increasing Cystic Fibrosis Transmembrane Conductance Regulator Open Probability (PLoS ONE (2014) 9:1 (DOI:10.1371/annotation/d852ff1d-2824- 4f4d-80f2-9be7a42a5f25)).
PLoS ONE.
9.
2014
|
|
| 2014
|
A survey of detergents for the purification of stable, active human cystic fibrosis transmembrane conductance regulator (CFTR)
2014
|
|
| 2014
|
Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation
2014
|
|
| 2014
|
Correction to Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation [Journal of Cell Biology, 206, 7, (2014), 867-876]
2014
|
|
| 2014
|
Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses.
Journal of Immunological Methods.
409:161-173.
2014
|
|
| 2014
|
Membrane protein stability can be compromised by detergent interactions with the extramembranous soluble domains.
Protein Science.
23:769-789.
2014
|
|
| 2014
|
Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells.
Journal of Immunological Methods.
409:147-160.
2014
|
|
| 2014
|
Vaginal myeloid dendritic cells transmit founder HIV-1.
Journal of Virology.
88:7683-7688.
2014
|
|
| 2013
|
Relative resistance of HIV-1 founder viruses to control by interferon-alpha.
Retrovirology.
10.
2013
|
|
| 2013
|
Impact of HIV-1 backbone on neutralization sensitivity: Neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01-AE backbone.
PLoS ONE.
8.
2013
|
|
| 2013
|
Detection of HIV-1 neutralizing antibodies in a human CD4 +/CXCR4+/CCR5+ T-lymphoblastoid cell assay system.
PLoS ONE.
8.
2013
|
|
| 2013
|
Resveratrol enhances airway surface liquid depth in sinonasal epithelium by increasing cystic fibrosis transmembrane conductance regulator open probability.
PLoS ONE.
8.
2013
|
|
| 2013
|
The silent codon change I507-ATC→ATT contributes to the severity of the AF508 CFTR channel dysfunction.
The FASEB Journal.
27:4630-4645.
2013
|
|
| 2013
|
Lyn Facilitates Glioblastoma Cell Survival under Conditions of Nutrient Deprivation by Promoting Autophagy.
PLoS ONE.
8.
2013
|
|
| 2013
|
Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees.
Journal of Virology.
87:7828-7836.
2013
|
|
| 2013
|
Mice Transgenic for CD4-Specific Human CD4, CCR5 and Cyclin T1 Expression: A New Model for Investigating HIV-1 Transmission and Treatment Efficacy.
PLoS ONE.
8.
2013
|
|
| 2013
|
Phenotypic properties of transmitted founder HIV-1
2013
|
|
| 2013
|
L1CAM stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor.
Clinical and Experimental Metastasis.
30:507-520.
2013
|
|
| 2013
|
Optimization of the transductional efficiency of lentiviral vectors: Effect of sera and polycations.
Molecular Biotechnology.
53:308-314.
2013
|
|
| 2013
|
Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones.
Virology.
436:33-48.
2013
|
|
| 2013
|
Mucosal tissue tropism and dissemination of HIV-1 subtype B acute envelope-expressing chimeric virus.
Journal of Virology.
87:890-899.
2013
|
|
| 2012
|
HIV-1 Expressing the Envelopes of Transmitted/Founder or Control/Reference Viruses Have Similar Infection Patterns of CD4 T-Cells in Human Cervical Tissue Ex Vivo.
PLoS ONE.
7.
2012
|
|
| 2012
|
Short communication: HIV type 1 escapes inactivation by saliva via rapid escape into oral epithelial cells.
AIDS Research and Human Retroviruses.
28:1574-1578.
2012
|
|
| 2012
|
A young hispanic with c.1646G>A mutation exhibits severe cystic fibrosis lung disease: Is ivacaftor an option for therapy?.
American Journal of Respiratory and Critical Care Medicine.
186:694-696.
2012
|
|
| 2012
|
Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.
Journal of Virology.
86:9055-9069.
2012
|
|
| 2012
|
Antibody-dependent cellular cytotoxicity against primary hivinfected CD4 + T cells is directly associated with the magnitude of surface igg binding.
Journal of Virology.
86:8672-8680.
2012
|
|
| 2012
|
Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials.
Journal of Infectious Diseases.
206:431-441.
2012
|
|
| 2012
|
Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication.
Journal of Virology.
86:6835-6846.
2012
|
|
| 2012
|
Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract.
PLoS ONE.
7.
2012
|
|
| 2012
|
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7.
PLoS Pathogens.
8.
2012
|
|
| 2012
|
The role of natural killer (NK) cells and nk cell receptor polymorphisms in the assessment of HIV-1 neutralization.
PLoS ONE.
7.
2012
|
|
| 2012
|
Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages.
Journal of Virology.
86:2715-2728.
2012
|
|
| 2012
|
Purification of CFTR for mass spectrometry analysis: Identification of palmitoylation and other post-translational modifications
2012
|
|
| 2011
|
IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation.
AIDS.
25:2099-2104.
2011
|
|
| 2011
|
Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection.
Journal of Virology.
85:11196-11207.
2011
|
|
| 2011
|
L1 stimulation of human glioma cell motility correlates with FAK activation.
Journal of Neuro-Oncology.
105:27-44.
2011
|
|
| 2011
|
High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses
2011
|
|
| 2011
|
An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum.
Journal of Virology.
85:7029-7036.
2011
|
|
| 2011
|
Stromal down-regulation of macrophage CD4/CCR5 expression and NF-κB activation mediates HIV-1 non-permissiveness in intestinal macrophages.
PLoS Pathogens.
7.
2011
|
|
| 2011
|
Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner.
Neuro-Oncology.
13:28-41.
2011
|
|
| 2010
|
Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC.
Virology.
408:1-13.
2010
|
|
| 2010
|
Uterine epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans infection by immature dendritic cells.
PLoS ONE.
5.
2010
|
|
| 2010
|
A synonymous single nucleotide polymorphism in ΔF508 CFTR alters the secondary structure of the mRNA and the expression of the mutant protein.
Journal of Biological Chemistry.
285:28741-28748.
2010
|
|
| 2010
|
Anti-HIV activity in cervical-vaginal secretions from HIV-Positive and -Negative women correlate with innate antimicrobial levels and IgG antibodies.
PLoS ONE.
5.
2010
|
|
| 2010
|
Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination.
Journal of Virology.
84:4998-5006.
2010
|
|
| 2010
|
Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines.
Journal of Experimental Medicine.
207:763-776.
2010
|
|
| 2010
|
GP41-specific antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonic epithelium.
Journal of Immunology.
184:3648-3655.
2010
|
|
| 2010
|
Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection.
European Journal of Immunology.
40:949-954.
2010
|
|
| 2010
|
Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production.
AIDS Research and Human Retroviruses.
26:279-291.
2010
|
|
| 2009
|
Cystin localizes to primary cilia via membrane microdomains and a targeting motif.
Journal of the American Society of Nephrology.
20:2570-2580.
2009
|
|
| 2009
|
Tetherin-Driven Adaptation of Vpu and Nef Function and the Evolution of Pandemic and Nonpandemic HIV-1 Strains.
Cell Host and Microbe.
6:409-421.
2009
|
|
| 2009
|
P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays.
Retrovirology.
6.
2009
|
|
| 2009
|
P04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific.
Retrovirology.
6.
2009
|
|
| 2009
|
P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.
Retrovirology.
6.
2009
|
|
| 2009
|
P20-15. Evaluation of HIV-1 subtype B acute envelope-expressing infectious molecular clones.
Retrovirology.
6.
2009
|
|
| 2009
|
S01-04 OA. Phenotypic analyses of CD8+ T cells that mediate virus inhibition from HIV-1 vaccinees and HIV-1+ virus controllers.
Retrovirology.
6.
2009
|
|
| 2009
|
Clinical and molecular characterization of S1118F-CFTR.
Pediatric Pulmonology.
44:1003-1009.
2009
|
|
| 2009
|
New virologic reagents for neutralizing antibody assays.
Current Opinion in HIV and AIDS.
4:418-425.
2009
|
|
| 2009
|
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.
Journal of Experimental Medicine.
206:1273-1289.
2009
|
|
| 2009
|
COP9-associated CSN5 regulates exosomal protein deubiquitination and sorting.
American Journal of Pathology.
174:1415-1425.
2009
|
|
| 2009
|
Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes..
AIDS.
23:2069-2077.
2009
|
|
| 2008
|
Calmodulin binding to cellular FLICE-like inhibitory protein modulates Fas-induced signalling.
Biochemical Journal.
412:459-468.
2008
|
|
| 2008
|
Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling.
Journal of Biological Chemistry.
283:15319-15327.
2008
|
|
| 2007
|
Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.
AIDS.
21:2387-2397.
2007
|
|
| 2007
|
Neural progenitor cell transplantation and imaging in a large animal model.
Neuroscience Research.
59:327-340.
2007
|
|
| 2007
|
HIV-1 Protease Dimer Interface Mutations that Compensate for Viral Reverse Transcriptase Instability in Infectious Virions.
Journal of Molecular Biology.
372:369-381.
2007
|
|
| 2007
|
Breast cancer metastasis to bone: Evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice.
Clinical and Experimental Metastasis.
24:389-401.
2007
|
|
| 2007
|
Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.
Journal of Virology.
81:7238-7248.
2007
|
|
| 2007
|
Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host.
Blood.
109:4336-4342.
2007
|
|
| 2007
|
Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy
2007
|
|
| 2007
|
Analysis of Amino Acids in the β7-β8 Loop of Human Immunodeficiency Virus Type 1 Reverse Transcriptase for their Role in Virus Replication.
Journal of Molecular Biology.
365:1368-1378.
2007
|
|
| 2006
|
Tethering KSRP, a decay-promoting AU-rich element-binding protein, to mRNAs elicits mRNA decay.
Molecular and Cellular Biology.
26:3695-3706.
2006
|
|
| 2006
|
Kinetics of metastatic breast cancer cell trafficking in bone.
Clinical Cancer Research.
12:1431-1440.
2006
|
|
| 2006
|
Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function.
Journal of Immunology.
176:1375-1385.
2006
|
|
| 2005
|
Analysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells.
Antimicrobial Agents and Chemotherapy.
49:3762-3769.
2005
|
|
| 2005
|
Identification of amino acid residues in the human immunodeficiency virus type-1 reverse transcriptase tryptophan-repeat motif that are required for subunit interaction using infectious virions.
Journal of Molecular Biology.
349:673-684.
2005
|
|
| 2004
|
Clonal selection for transcriptionally active viral oncogenes during progression to cancer.
Journal of Virology.
78:11172-11186.
2004
|
|
| 2004
|
Evidence that stable retroviral transduction and cell survival following DNA integration depend on components of the nonhomologous end joining repair pathway.
Journal of Virology.
78:8573-8581.
2004
|
|
| 2004
|
Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.
Journal of Virology.
78:7089-7096.
2004
|
|
| 2003
|
Replication of chimeric human immunodeficiency virus type 1 (HIV-1) containing HIV-2 integrase (IN): Naturally selected mutations in IN augment DNA synthesis.
Journal of Virology.
77:11050-11059.
2003
|
|
| 2003
|
Erratum: Antibody neutralization and escape by HIV-1 (Nature (2003) 422 (307-312)).
Nature.
423:197.
2003
|
|
| 2003
|
Antibody neutralization and escape by HIV-1.
Nature.
422:307-312.
2003
|
|
| 2003
|
Production of trans-lentiviral vector with predictable safety..
Methods in Molecular Medicine.
76:449-465.
2003
|
|
| 2002
|
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.
Antimicrobial Agents and Chemotherapy.
46:1896-1905.
2002
|
|
| 2002
|
The promoter of the human proliferating cell nuclear antigen gene is not sufficient for cell cycle-dependent regulation in organotypic cultures of keratinocytes.
Journal of Biological Chemistry.
277:17271-17280.
2002
|
|
| 2002
|
The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.
Journal of Virology.
76:4331-4340.
2002
|
|
| 2002
|
Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells.
Nature Medicine.
8:150-156.
2002
|
|
| 2001
|
Moloney murine leukemia virus integrase protein augments viral DNA synthesis in infected cells.
Journal of Virology.
75:11365-11372.
2001
|
|
| 2001
|
Safety considerations in vector development.
Somatic Cell and Molecular Genetics.
26:147-158.
2001
|
|
| 2001
|
Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1.
Nature Medicine.
7:920-926.
2001
|
|
| 2001
|
Analysis of lenti- and trans-lentiviral vector genetic recombination.
2001
|
|
| 2000
|
Analysis of human immunodeficiency virus type 1 containing HERV-K protease.
AIDS Research and Human Retroviruses.
16:1973-1980.
2000
|
|
| 2000
|
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.
Journal of Virology.
74:8358-8367.
2000
|
|
| 2000
|
Development of a novel trans-lentiviral vector that affords predictable safety.
Molecular Therapy.
2:47-55.
2000
|
|
| 2000
|
Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice.
STEM CELLS.
18:352-359.
2000
|
|
| 1999
|
Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex.
Journal of Virology.
73:2126-2135.
1999
|
|
| 1999
|
Targeting human immunodeficiency virus (HIV) type 2 integrase protein into HIV type 1.
Journal of Virology.
73:8831-8836.
1999
|
|
| 1998
|
The cysteine-cysteine family of chemokines RANTES, MIP-1α, and MIP-1β induce trypanocidal activity in human macrophages via nitric oxide.
Infection and Immunity.
66:4690-4695.
1998
|
|
| 1997
|
Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein
1997
|
|
| 1997
|
Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
Journal of Virology.
71:7704-7710.
1997
|
|
| 1996
|
Proteolytic activity of human immunodeficiency virus Vpr-and Vpx-protease fusion proteins.
Virology.
219:307-313.
1996
|
|
| 1996
|
Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.
Journal of Virology.
70:3378-3384.
1996
|
|
| 1995
|
Assessment of antiretroviral therapy by plasma viral load testing: Standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared
1995
|
|
| 1995
|
Polyclonal Rabbit Antisera that Detect the Vpr Protein of SIVSM and SIVMAC on Immunoblots of Purified Virions.
AIDS Research and Human Retroviruses.
11:405-408.
1995
|
|
| 1995
|
Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.
Journal of Virology.
69:3389-3398.
1995
|
|
| 1995
|
The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.
Journal of Virology.
69:7630-7638.
1995
|
|
| 1995
|
Viral protein X.
Current Topics in Microbiology and Immunology.
193:121-132.
1995
|
|
| 1994
|
Optimization of quantitative culture assay for human immunodeficiency virus from plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of Allergy and Infectious Diseases)..
Journal of Clinical Microbiology.
32:3064-3067.
1994
|
|
| 1994
|
Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.
Journal of Virology.
68:6161-6169.
1994
|
|
| 1994
|
Optimization of quantitative culture assay for human immunodeficiency virus from plasma.
Journal of Clinical Microbiology.
32:3064-3067.
1994
|
|
| 1993
|
A Short-Term Clinical Evaluation of L-697,661, a Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase.
New England Journal of Medicine.
329:1065-1072.
1993
|
|
| 1993
|
Viral dynamics in primary HIV-1 infection
1993
|
|
| 1993
|
Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction.
AIDS.
7.
1993
|
|
| 1993
|
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.
Science.
259:1749-1754.
1993
|
|
| 1993
|
Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components.
Virology.
193:222-233.
1993
|
|
| 1993
|
Viral dynamics in primary HIV-1 infection [21]
1993
|
|
| 1992
|
In vitro and in vivo anti-viral activity of a purified fraction of bovine lecithin against Herpes simplex virus.
Medical Science Research.
20:441-443.
1992
|
|
| 1991
|
High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.
New England Journal of Medicine.
324:954-960.
1991
|
|
| 1991
|
Human immunodeficiency virus type 2 vpx protein augments viral infectivity.
Virology.
184:197-209.
1991
|
|
| 1991
|
Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and -defective viral genomes.
Journal of Virology.
65:3973-3985.
1991
|
|
| 1990
|
Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate.
Journal of Virology.
64:890-901.
1990
|
|
| 1988
|
Enhanced in vitro reactivation of latent herpes simplex virus from neural and peripheral tissues with hexamethylenebisacetamide.
Archives of Virology.
99:57-65.
1988
|
|
| 1988
|
Antibody to herpes simplex virus (Hsv) icp-35 proteins after hsv challenge of animals immunized with hsv subunit vaccines.
Journal of Infectious Diseases.
157:1178-1186.
1988
|
|
| 1988
|
Enhanced in vitro reactivation of herpes simplex virus type 2 from latency infected guinea-pig neural tissues by 5-azacytidine.
Journal of General Virology.
69:1079-1083.
1988
|
|
| 1988
|
Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIV(MAC).
Journal of Virology.
62:3501-3505.
1988
|
|
| 1988
|
West African HIV-2-related human retrovirus with attenuated cytopathicity.
Science.
240:1525-1529.
1988
|
|
| 1987
|
Antibody Response to Herpes Simplex Virus Glycoprotein d: Effects of Acyclovir and Relation to Recurrence.
Journal of Infectious Diseases.
156:423-429.
1987
|
|
| 1986
|
Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: Effects of acyclovir.
Journal of General Virology.
67:1601-1612.
1986
|
|
| 1985
|
Further studies on in vitro suppression of rotavirus using a purified fraction of bovine lecithin.
IRCS Medical Science.
13:997-998.
1985
|
|
| 1985
|
In vitro suppression of rotavirus replication using a purified fraction of bovine lecithin.
IRCS Medical Science.
13:595-596.
1985
|
|
| 1984
|
Lysosomal stimulation of mouse peritoneal macrophages by purified bovine lecithin.
IRCS Medical Science.
12:206-207.
1984
|
|
| 1983
|
The effect of phosphatidylcholine on the reticuloendothelial system, as determined by carbon clearance assay.
IRCS Medical Science.
11:389.
1983
|
|
